Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Winkler, K; Abletshauser, C; Hoffmann, MM; Friedrich, I; Baumstark, MW; Wieland, H; März, W.
Effect of fluvastatin slow-release on low density lipoprotein (LDL) subfractions in patients with type 2 diabetes mellitus: baseline LDL profile determines specific mode of action.
J Clin Endocrinol Metab. 2002; 87(12):5485-5490 Doi: 10.1210/jc.2002-020370 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Co-Autor*innen der Med Uni Graz
März Winfried
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
The objective of this study was to determine the effect of slow-release (XL) fluvastatin on low density lipoprotein (LDL) subfractions in type 2 diabetes. A multicenter, double-blind, randomized, parallel-group comparison of fluvastatin XL 80 mg (n = 42) and placebo (n = 47), each given once-daily for 8 wk, in 89 patients with type 2 diabetes (HbA1c: 7.2 +/- 1.0%, LDL cholesterol (LDL-C): 3.4 +/- 0.7 mmol/liter, high density lipoprotein cholesterol: 1.1 +/- 0.3 mmol/liter, and triglycerides (TG): 2.4 +/- 1.4 mmol/liter). At baseline and on treatment, plasma lipoproteins were isolated and quantified. Eight weeks of fluvastatin treatment decreased total cholesterol (-23.0%, P < 0.001), LDL-C (-29%, P < 0.001) and TG (-18%, P < 0.001), compared with placebo. At baseline, there was a preponderance of dense LDL (dLDL) (apolipoprotein B in LDL-5 plus LDL-6 > 25 mg/dl) in 79% of patients, among whom fluvastatin decreased all LDL subfractions, reductions in dLDL being greatest (-28%, P = 0.001; cholesterol in dLDL -29%). In patients with low baseline dLDL (apolipoprotein B in LDL-5 plus LDL-6
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Apolipoproteins - blood
Delayed-Action Preparations - blood
Diabetes Mellitus, Type 2 - blood
Double-Blind Method - blood
Fatty Acids, Monounsaturated - administration and dosage
Female - administration and dosage
Humans - administration and dosage
Indoles - administration and dosage
Lipids - blood
Lipoproteins - blood
Lipoproteins, LDL - blood
Male - blood
Middle Aged - blood
Safety - blood

© Med Uni Graz Impressum